The negative reaction in ModivCare's stock price is directly tied to its reported financial performance and future revenue outlook, which did not meet analyst expectations. This has led to a loss of confidence among investors, reflected in stock downgrades and reduced price targets by multiple firms. Such financial results and subsequent analyst actions typically have a direct and negative short-term impact on a company's stock price.